Press "Enter" to skip to content

New patent for Aerie Pharms drug RHOPRESSA

3
Copyright © DrugPatentWatch. Originally published at New patent for Aerie Pharms drug RHOPRESSA

Annual Drug Patent Expirations for RHOPRESSA
Annual Drug Patent Expirations for RHOPRESSA

Rhopressa is a drug marketed by Aerie Pharms Inc and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.

RHOPRESSA drug price trends.

This drug has fifty patent family members in eight countries.

The generic ingredient in RHOPRESSA is netarsudil mesylate. One supplier is listed for this compound. Additional details are available on the netarsudil mesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Aerie Pharms drug RHOPRESSA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions